Found 7 matching trials
A Study to Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 (COVID-19) Variants
PHASE2This is a study to evaluate the immunogenicity, safety, and reactogenicity ...
Location
Benchmark Research (California)
Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA Vaccines
PHASE1A phase 1/2, open-label clinical trial in individuals, 18 years of age and ...
Location
The Hope Clinic of Emory University
Safety and Immunogenicity of Omicron Variant-Matched Vaccine Booster in Adults
PHASE2Under protocol versions 1.01-1.06: The five recently emerged SARS-CoV2 vari...
Location
Sheba Medical Center
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19
PHASE3The purpose of this study (Part 1 and Part 2) is to evaluate the relative v...
A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19
PHASE2The mRNA-1273 vaccine is being developed to prevent COVID-19, the disease r...
Location
Velocity Clinical Research - Banning
Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of Concern
PHASE2The study will evaluate the clinical efficacy of different dosing regimens ...
An Observational Study of Moderna COVID-19 Bivalent Vaccines (Original and Omicron BA.4/BA.5) and 2023 Updated mRNA COVID-19 Vaccines (XBB.1.5)
N/AThe goal of this observational study is to analyze binding antibody levels ...